![]()
|
|
||||||||
(Received for publication, July 15, 1997, and in revised form, August 4, 1997)

From the Gifford Laboratories, Center for Diabetes Research, Departments of Internal Medicine and Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75235 and the Department of Veterans Affairs Medical Center, Dallas, Texas 75216
To determine if underleptinization of islets of
Zucker diabetic fatty (ZDF) rats is the proximal cause of their
inability to compensate for obesity, we compared the
proinsulin/
-actin mRNA ratio in heterozygous (fa/+)
ZDF rats with that of wild-type (+/+) and homozygous
(fa/fa) ZDF rats. In +/+ islets cultured with 2 mM free fatty acids (FFA) the proinsulin mRNA ratio
rose 2.4-fold at 12 h. In fa/+ islets, the ratio rose
only 65% above normal. There was no change in fa/fa
islets. The presence of leptin (20 ng/ml) in the culture medium
increased the FFA-induced response of proinsulin mRNA of
fa/+ islets to that of +/+ islets while reducing FFA
incorporation into triglycerides. The leptin-induced improvement in the
proinsulin mRNA response was independent of any changes in glucose
usage. These findings support a causal relationship between diminished
leptin action on islets and the impaired
-cell response to FFA in
ZDF rats.
Resistance to leptin is a common feature in both human and rodent
obesity (1-3). In db/db mice and fa/fa rats, it
is the consequence of mutations in the leptin receptor (OB-R) (4-6), whereas in obese leptin-resistant humans an unidentified post-receptor defect may be the cause (7). Recent studies in our lab suggest that
-cell compensation for the insulin resistance of adiposity is, at
least in part, driven by the accompanying elevations of long-chain free
fatty acids (FFA)1 in tissues
and plasma (8, 9). Since leptin regulates the metabolic fate of FFA in
tissues by blocking intracellular esterification and by enhancing
intracellular oxidation (10), leptin action may influence the ability
of
-cells to augment insulin production in response to FFA. Indeed,
in leptin-resistant obese Zucker diabetic fatty (ZDF) rats with
defective leptin receptors (5, 6), there is a marked increase in the
triglyceride (TG) content in islets during the developement of the
-cell defects of adipogenic diabetes, so-called "lipotoxicity"
(11). In other words, "underleptinization" might be the proximal
cause of the
-cell dysfunction that results in the
noninsulin-dependent diabetes mellitus of ZDF rats.
To test this hypothesis, we compared the effect of leptin upon FFA-induced up-regulation of proinsulin mRNA in islets of lean wild-type ZDF rats (+/+), of obese prediabetic ZDF rats, which are homozygous for the mutation in the leptin receptor (fa/fa), and of lean heterozygous ZDF rats (fa/+). The islets of +/+ ZDF rats are entirely normal and fully responsive to the lipopenic action of leptin (10), whereas the fat-laden islets of fa/fa ZDF rats are completely unresponsive to leptin (10) and cannot be used to study leptin action. The islets of lean heterozygous ZDF rats with a single normal OB-R allele, therefore, became the focus of this study. Their fat content is slightly higher than islets of wild-type ZDF rats (12), and, as in homozygous rats, they do not mount a normal compensatory increase in insulin production in response to FFA (9). Nevertheless, since high levels of leptin will reduce their fat content (10), they can be employed to test the premise that leptin action plays a role in the FFA-induced increase in proinsulin gene expression. The following studies were designed to test this hypothesis.
All groups of rats were studied at 7 weeks of age. Homozygous male obese prediabetic ZDF-drt rats (fa/fa), which become diabetic at 8-10 weeks of age, heterozygous lean ZDF littermates (fa/+), and wild-type lean ZDF rats (+/+) were bred in our laboratory from ZDF/drt-fa (F10) stock purchased from Dr. Richard Peterson (University of Indianapolis School of Medicine, Indianapolis, IN). All rats received standard rat chow (Teklad F6 8664, Teklad, Madison, WI) ad libitum and had free access to water. The institutional guidelines for animal care and use were followed.
Genotyping of ZDF AnimalsDNA was extracted from rat tails
(~8 mm) by proteinase K digestion followed by phenol/chloroform
extraction and ethanol precipitation (13). Primers
5
-GTTTGCGTATGCAAGTCACAG-3
and 5
-ACCAGCAGAGATTCCGAG-3
were used to
amplify products from 5 ng of genomic DNA in a 50-µl reaction
mixture. A polymerase chain reaction (PCR) protocol of 30 cycles of
94 °C for 1 min, 55 °C for 90 s, and 68 °C for 5 min was
employed. PCR products were digested with the restriction enzyme
MspI for 2 h at 37 °C and analyzed on a 2% agarose
gel (5).
Pancreatic islets were isolated from 7-week-old rats by the method of Naber et al. (14) as modified by Lee et al. (15). They were maintained for 3 days in suspension culture in 60-mm glass Petri dishes at 37 °C in a humidified atmosphere of 5% CO2 and 95% air as described previously (8). The culture consisted of RPMI 1640 medium supplemented with 8.0 mM glucose, 10% fetal bovine serum, 200 units/ml penicillin, 0.2 mg/ml streptomycin, and 2% bovine serum albumin, fraction V (Bayer Corp., Kankakee, IL). In some experiments, 20 ng/ml recombinant leptin (kindly provided by Todd Kirchgessner, Bristol-Myers Squibb) and/or 2 mM of a 2:1 oleate:palmitate mixture in 2% albumin were added to the culture medium (Sigma).
Measurements of Glucose UsageGlucose usage in cultured islets was measured by the method of Zawalich and Matchinsky (16) and Zawalich et al. (17), as described previously (8).
RNA Extraction and Reverse Transcription PCRTotal RNA was
extracted from islets by the TRIzol isolation method (Life
Technologies, Gaithersburg, MD) from about 200 isolated islets. 2-µg
aliquots of total RNA were treated with RNase-free DNase (Promega), and
the first-strand cDNA synthesis was carried out using the oligod(T)
primer in 1st-strandTM cDNA synthesis kit
(CLONTECH). The primers used were:
5
-TGCCCGGGCTTTTGT CAAAC-3
for insulin sense primer and
5
-CTCCAGTGCCAAGGTCTGAA-3
for insulin antisense primer, corresponding
to 4244-4263 and 4411-4430 base pairs of the proinsulin sequence
(GeneBankTM Data Bank accession number J00747); and
5
-TTGTAACCAACTGGGGACGATATGG-3
for
-actin sense primer and
5
-GATCTTGATCTTCATGGTGCTAGG-3
for
-actin antisense primer,
corresponding to 1552-1575 and 2968-2991 base pairs of the
-actin
sequence (GeneBankTM Data Bank accession number J00691).
Linearity of the PCR reaction was tested by amplification of 100 ng
first-strand cDNA per reaction from 10 to 45 cycles. The linear
range was found to be between 10 and 35 cycles. In no case did the
amount of first-strand cDNA used for PCR reaction exceed 100 ng per
reaction. The samples were amplified for 22 cycles using the following
parameters: 92 °C for 1 min, 53 °C for 45 s, and 72 °C
for 45 s. The PCR products were subjected to electrophoresis on an
agarose gel, and Southern blotting was carried out on a nylon membrane.
The membrane was hybridized with 32P-labeled internal oligo
primers (5
-ACACACCAGGTACAGAGCCTCCACCAGGTG-3
for proinsulin and
5
-GGTCAGGATCTTCATGAGGTAGTCTGTCAG-3
for
-actin). Insulin mRNA
and
-actin mRNA levels were quantified using the phosphorimager.
-actin was employed as an internal standard for normalizing proinsulin mRNA.
After the 3-day culture period in medium containing either 0 or 2 mM FFA, islets from all groups of rats were randomly selected, washed twice with PBS, and stained with fluorescein diacetate and ethidium bromide for 1 min. Approximately 500 cells from each of the six groups were counted at random under a fluorescence microscope (Nikon Optiphot UFX 1-A, Garden City, NY). Green cells were counted as viable and red cells as dead. The data were expressed as percent viability.
Statistical AnalysisAll results are expressed as ± S.E. Statistical significance was evaluated using Student's t test on two-way analysis of variance followed by Scheffe's multiple comparison.
-Actin mRNA Ratio in Normal
Islets
The effect of 2 mM FFA on the
proinsulin/
-actin mRNA ratio is shown in Fig.
1. FFA up-regulated proinsulin mRNA
to a peak 2.4-fold of the control level at 12 h after the start of
culture. By contrast, up-regulation of the proinsulin mRNA ratio by
16 mM glucose reached a peak 3 times the control value at
4 h (Fig. 1).
-actin mRNA ratio in normal islets from wild-type
(+/+) ZDF rats cultured in 2 mM FFA or 16 mM
glucose.
Effect of FFA on Proinsulin/
-Actin mRNA Ratio in Islets with
Mutated Leptin Receptors
Enhancement of insulin production by FFA
does not occur in islets from rats that are either homozygous
(fa/fa) or heterozygous (fa/+) for a mutant
leptin receptor (9). We determined if the failure of islets of ZDF rats
to increase insulin production in response to FFA was associated with
impairment of the response of the proinsulin mRNA/
-actin
mRNA ratio. In contrast to the 2.4-fold increase in proinsulin
mRNA in islets from normal wild-type (+/+) ZDF rats, it rose by
only 65% in islets from the heterozygous (fa/+), while the
ratio remained unchanged in homozygous (fa/fa) rats (Fig.
2). Thus, the full FFA-induced response
in proinsulin mRNA, like the previously reported FFA-induced
changes in insulin secretion (8, 9), seems to require the presence of
two normal leptin receptor alleles.
-actin
mRNA ratio in islets from wild-type (+/+), heterozygous (fa/+), and
homozygous (fa/fa) ZDF rats after 3 days in culture medium containing 0 or 2 mM FFA.
To exclude the possibility that these differences in proinsulin
mRNA were the spurious consequence of a greater cytotoxic effect of
the 2 mM FFA on leptin receptor-defective
-cells, we conducted viability studies on islets from the three groups after culture for 3 days in the presence or absence of 2 mM FFA.
FFA reduced the percent of viable cells in islets from wild-type ZDF rats by 8%, compared with 11 and 13% in islets from heterozygous and
homozygous ZDF rats, respectively. These small intergroup differences
in viability were regarded as insufficient to explain the large
differences in FFA-induced insulin gene expression.
To determine
whether the failure of insulin gene expression to respond to FFA
represented an FFA-restricted defect or a nonspecific and general
inability to respond to increased insulin demand, we compared the
proinsulin/
-actin mRNA ratio in islets from the three groups of
rats cultured for 3 days in the presence of 8 or 16 mM
glucose. As shown in Fig. 3, the
proinsulin mRNA ratio in islets from fa/fa rats was not
increased by glucose, perhaps because the massive increase in fat
content had seriously impaired the ability of
-cell to respond to
any increase in insulin need. However, in islets from heterozygous ZDF
rats, 16 mM glucose induced a greater than 2.5-fold
increase in proinsulin mRNA, not significantly different from the
proinsulin mRNA response to glucose of islets from wild-type ZDF
rats, whereas the response to FFA was only 30% of that of wild-type
rats. Thus, the defect in islets of heterozygous ZDF rats seemed to be
FFA-restricted without impairment of the glucose-induced response of
proinsulin mRNA.
-actin mRNA
ratio in islets from wild-type (+/+), heterozygous (fa/+), and
homozygous (fa/fa) ZDF rats after 3 days in culture medium containing 8 or 16 mM glucose.
Effects of Leptin on FFA-induced Proinsulin mRNA
Previous
findings from this laboratory indicate that in normal islets leptin
promotes the channeling of FFA into oxidative rather than lipogenic
pathways (10). Since islets of fa/fa rats cannot respond to
leptin (10), they have an increased rate of FFA esterification (12),
islet TG content rises to extremely high levels (15), and FFA
enhancement of
-cell function is somehow blocked. Islets of
heterozygous rats, by contrast, have a much less marked increase in TG
content (12), but FFA enhancement of
-cell function is,
nevertheless, attenuated. However, their islets respond partially to 20 ng/ml leptin with a lowering of TG content, as shown in Table
I (10). To determine if exposure to
leptin would repair the partial defect in the response of proinsulin mRNA to FFA, we added 20 ng/ml recombinant hormone to the culture medium and reassessed the effect of FFA on proinsulin mRNA. The presence of leptin in the culture medium reduced the increase in TG
otherwise observed in islets of heterozygous rats cultured in the
presence of 1 mM FFA from 27 ng/islet to only 4.6 ng/islet (Table I). Concomitantly, the response of proinsulin mRNA to FFA
was restored to normal (Fig. 4); by
contrast, in islets of homozygous ZDF rats, neither the TG content nor
FFA induction of proinsulin mRNA were affected by leptin.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
-actin mRNA
ratio in islets from wild-type (+/+), heterozygous (fa/+), and
homozygous (fa/fa) cultured for 24 h with or without 2 mM FFA after 2 days of pretreatment with or without 20 ng/ml of leptin.
Relationship of FFA-mediated Increase in Low Km Glucose Usage to the Increase in Proinsulin mRNA
We have previously reported that FFA cause an increase in low Km glucose usage by islets (8, 9). Since insulin production varies with glucose metabolism by islets (18, 19), it seemed possible that FFA effects on insulin gene expression were mediated by the increase in glucose usage. We, therefore, compared the chronology of the FFA-induced proinsulin mRNA response and the rise in low Km glucose usage. As shown in Table II, glucose usage was rising at 12 h, the time at which the FFA-induced increase was at its peak. This indicated that the improved effect of FFA on proinsulin mRNA might have been mediated via enhanced glucose metabolism.
|
||||||||||||||||||||||||||||||
Since the foregoing result did not prove a relationship between low Km glucose usage and proinsulin mRNA up-regulation, we exploited the fact that the normal up-regulatory effect of FFA on proinsulin mRNA is absent in cultured islets of heterozygous ZDF rats but is restored by exposure of the islets to leptin (Fig. 4). Low Km glucose usage should also be improved by leptin if the leptin-induced improvement in the proinsulin mRNA response to FFA were mediated by increased glucose metabolism. As shown in Table II, leptin did not increase low Km glucose usage, indicating that the leptin-mediated normalization of proinsulin mRNA does not depend upon an increase in low Km glucose usage.
There is now substantial evidence to indicate that the increased
insulin production required to compensate for obesity-induced insulin
resistance is stimulated by fatty acids reaching the islets (8, 9). As
a consequence of higher circulating FFA levels (15), coupled with a
dramatically increased esterification capacity resulting from the lack
of leptin action (12), the TG content of islets from obese prediabetic
ZDF rats, in which the
-cells have successfully compensated for the
concomitant insulin resistance, is ~13-17-fold that of lean Wistar
rats (12). The increased insulin production observed in vivo
in these obese compensated prediabetic rats can be duplicated in
vitro by culturing normal islets from lean rats in 1 or 2 mM FFA (8). We refer to these changes as
"compensatory."
Later in the course of prediabetic obesity, islet fat content rises to
50-100-fold that of lean Wistar rats, at which time basal and
stimulated insulin production significantly decline (15). These
in vivo changes can be duplicated in vitro by
culturing islets from compensated prediabetic obese rats in 1 or 2 mM FFA (9). We have referred to this effect of FFA on
-cell function as "lipotoxic" since we attribute it to the lipid
overload (11). More recent work suggests that lipotoxicity is mediated
by excessive levels of nitric oxide (NO) in islets (20).
Since leptin reduces islet TG via the leptin receptor (10), it was
logical to ascribe the fat overload of ZDF rats and the
-cell
dysfunction in these animals to their abnormal leptin receptor. However, since islets of homozygous ZDF rats cannot respond to leptin,
we could not test the validity of the premise that underleptinization causes their
-cell phenotype. We therefore employed islets of heterozygous fa/+ rats, which are responsive to high
concentrations of leptin (10) but which do not mount a normal
compensatory increase in insulin production response to FFA in
vitro. Leptin reduced the rise in islet TG that otherwise occurs
when islets from heterozygous ZDF islets are cultured in FFA, and this
was associated with normalization of the attenuated FFA-induced
response of the proinsulin/
-actin mRNA ratio. However, a causal
relationship between the elevated islet TG and the impairment in
FFA-induced compensatory changes of
-cells in fa/+ rats
is difficult to substantiate inasmuch as the differences in fat content
from +/+ controls are unimpressive. While it is possible that by
shifting FFA from esterification to other pathways in fa/+
islets, leptin provided the FFA substrate required to up-regulate
-cell function; however, a clearcut relationship between the
leptin-mediated improvement in FFA-induced proinsulin mRNA response
to the observed changes in lipid metabolism could not be
established.
Nor does it appear that the FFA-induced up-regulation of proinsulin mRNA is mediated by the previously demonstrated FFA-induced increase in low Km glucose metabolism (8, 9). If the proinsulin mRNA response to FFA had been secondary to increased low Km glucose usage, leptin treatment, which restored the impaired FFA-induced proinsulin mRNA response of fa/+ islets to normal, should also have restored to normal the FFA-mediated increase in low Km glucose usage. Since leptin failed to improve FFA induction of low Km glucose usage, we concluded that the amelioration in the proinsulin mRNA response attributed to leptin action was independent of changes in low Km glucose metabolism.
To whom correspondence should be addressed: Center for Diabetes
Research, University of Texas Southwestern Medical Center, 5323 Harry
Hines Blvd., Dallas, TX 75235-8854. Tel.: 214-648-6742; Fax:
214-648-9191.
We thank Dr. Chris Newgard for critically reviewing this paper, Kay McCorkle for technical support, and Sharryn Harris for secretarial assistance.
This article has been cited by other articles:
![]() |
T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E549 - E560. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Seufert Leptin Effects on Pancreatic {beta}-Cell Gene Expression and Function Diabetes, February 1, 2004; 53(90001): S152 - 158. [Abstract] [Full Text] |
||||
![]() |
H. Yamashita, J. Shao, T. Ishizuka, P. J. Klepcyk, P. Muhlenkamp, L. Qiao, N. Hoggard, and J. E. Friedman Leptin Administration Prevents Spontaneous Gestational Diabetes in Heterozygous Leprdb/+ Mice: Effects on Placental Leptin and Fetal Growth Endocrinology, July 1, 2001; 142(7): 2888 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Y. Wang, K. Koyama, M. Shimabukuro, C. B. Newgard, and R. H. Unger OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype PNAS, January 20, 1998; 95(2): 714 - 718. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |